| Literature DB >> 29330144 |
Sana Sarvi1, Hitesh Patel1, Jun Li1, Georgia L Dodd1, Helen Creedon1, Morwenna Muir1, Jocelyn Ward1, John C Dawson1, Martin Lee1, Jayne Culley1, Donald M Salter2, Andrew H Sims1, Adam Byron1, Valerie G Brunton3.
Abstract
In breast cancer, increased expression of the cytoskeletal adaptor protein Kindlin-1 has been linked to increased risks of lung metastasis, but the functional basis is unknown. Here, we show that in a mouse model of polyomavirus middle T antigen-induced mammary tumorigenesis, loss of Kindlin-1 reduced early pulmonary arrest and later development of lung metastasis. This phenotype relied on the ability of Kindlin-1 to bind and activate β integrin heterodimers. Kindlin-1 loss reduced α4 integrin-mediated adhesion of mammary tumor cells to the adhesion molecule VCAM-1 on endothelial cells. Treating mice with an anti-VCAM-1 blocking antibody prevented early pulmonary arrest. Kindlin-1 loss also resulted in reduced secretion of several factors linked to metastatic spread, including the lung metastasis regulator tenascin-C, showing that Kindlin-1 regulated metastatic dissemination by an additional mechanism in the tumor microenvironment. Overall, our results show that Kindlin-1 contributes functionally to early pulmonary metastasis of breast cancer.Significance: These findings provide a mechanistic proof in mice that Kindin-1, an integrin-binding adaptor protein, is a critical mediator of early lung metastasis of breast cancer. Cancer Res; 78(6); 1484-96. ©2018 AACR. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29330144 PMCID: PMC5857359 DOI: 10.1158/0008-5472.CAN-17-1518
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701